BB3-31047-44475
4 vaccinations
1 coded response
28 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 105 / NY
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-13
- 2021-01-20
-
2021-01-27
Dose 2 — Moderna
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-03-03
- 2021-03-10
- 2021-04-28
-
2021-07-28
Survey response — 6 months, dose 2MedDRA: Menstrual disorder — Feeling: GoodFree text: Change in menstrual period.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-17
Dose 3 — Moderna
- 2022-01-28
- 2022-05-18
-
2022-10-27
Dose 4 — Pfizer-BioNTech
- 2022-11-17
- 2022-11-17
- 2022-11-24
- 2022-12-01
- 2022-12-08
- 2023-01-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-11-17 | Moderna | No |
| 4 | 2022-10-27 | Pfizer-BioNTech | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: Change in menstrual period.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Menstrual disorder | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release